The rising use of inorganic methods such as facility expansion by the industry's top players is likely to fuel market growth during the forecast period. Acne drug pipeline expansion and rising frequency of acne-related diseases are projected to fuel market growth during the forecast period. High adverse effects associated with acne drugs and increased usage of alternative therapies are the primary factors impeding expansion in the global acne medication industry. The kind and strength of the therapy affect the negative effects of acne drugs.
According to Coherent Market Insights, Global Acne Medication Market is estimated to be valued at US$ 7,594.3 million in 2022 and is expected to exhibit a CAGR of 4.5% during the forecast period (2022-2030).
Market Leaders in the Acne Medication Industry:
Galderma Laboratories, L.P
Galderma is the world's largest independent dermatology company, present in approximately 100 countries. Founded in 1981, headquartered in Vaud, Switzerland. On March 25, 2022 Galderma announced the U.S. launch of TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1%/3% at the American Academy of Dermatology (AAD) Annual Meeting, March 25-29, 2022, in Boston, Massachusetts. TWYNEO Cream is the first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 combination proven to rapidly treat moderate to severe facial acne. In March 2021, Fortress Biotech, Inc., a biopharmaceutical company, announced a partnership with Journey Medical Corporation, a commercial-stage pharmaceutical company, to launch an oral isotretinoin under the brand name Accutane (isotretinoin capsules USP) in the U.S. Accutane is an oral medication that is indicated for the treatment of severe recalcitrant nodular acne.
GlaxoSmithKline plc.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV. Founded in 2000, headquartered in England, U.K.
Arctic Therapeutics International
Arcturus Therapeutics Holdings Inc. operates as a late-stage clinical mRNA medicines and vaccines company. Its technologies are covered by its patent portfolio, including patents and patent applications issued in the U.S., Europe, Japan, China, and other countries. The company was founded in 2013 and is headquartered in San Diego, California.
Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company was founded in 1983 and is based in Mumbai, India. In July 2022, Sun Pharmaceutical Industries, an India-based pharmaceutical company, announced partnership with Cassiopea SpA, a clinical stage specialty pharmaceutical company, regarding a medication to treat acne.